4.5 Article

Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model

期刊

DISEASE MODELS & MECHANISMS
卷 14, 期 5, 页码 -

出版社

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.047498

关键词

HNF1B transcription factor; RCAD syndrome; Gene dosage; Glomerular and proximal tubule cysts; Mouse models; Transcriptomics

资金

  1. GIS-Institut des Maladies Rares, Paris, France
  2. Institut Clinique de la Souris, Ilkirch, France
  3. Agence National de la Recherche [Blan06-2_139420]
  4. Institut National de la Sante et de la Recherche Medicale (INSERM, France)
  5. BOLD Marie Curie Initial Training Network (MCITN) EU Seventh Framework Programme [238821]
  6. EU Horizon 2020 Research and Innovation Programme under Marie Sklodowska-Curie grant [642937, MSCA-ITN-2014-642937]
  7. Centre National de la Recherche Scientifique (CNRS)
  8. Sorbonne Universite
  9. Biology of Liver and Pancreatic Development and Disease (BOLD) Marie Curie Initial Training Network (MCITN) EU Seventh Framework Programme [238821]
  10. Innovative Training Network RENALTRACT [MSCA-ITN2014-642937]
  11. Centre National de la Recherche Scientifique
  12. Marie Curie Actions (MSCA) [642937] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

A novel mouse model carrying a human mutation at the intron-2 splice donor site exhibited renal cysts and phenotypes associated with reduced HNF1B levels, revealing the molecular mechanisms and pathological characteristics of developmental disease phenotypes caused by HNF1B deficiency.
Heterozygous mutations in HNF1B cause the complex syndrome renal cysts and diabetes (RCAD), characterized by developmental abnormalities of the kidneys, genital tracts and pancreas, and a variety of renal, pancreas and liver dysfunctions. The pathogenesis underlying this syndrome remains unclear as mice with heterozygous null mutations have no phenotype, while constitutive/conditional Hnf1b ablation leads to more severe phenotypes. We generated a novel mouse model carrying an identified human mutation at the intron-2 splice donor site. Unlike heterozygous mice previously characterized, mice heterozygous for the splicing mutation exhibited decreased HNF1B protein levels and bilateral renal cysts from embryonic day 15, originated from glomeruli, early proximal tubules (PTs) and intermediate nephron segments, concurrently with delayed PT differentiation, hydronephrosis and rare genital tract anomalies. Consistently, mRNA sequencing showed that most downregulated genes in embryonic kidneys were primarily expressed in early PTs and the loop of Henle and involved in ion/drug transport, organic acid and lipid metabolic processes, while the expression of previously identified targets upon Hnf1b ablation, including cystic disease genes, was weakly or not affected. Postnatal analyses revealed renal abnormalities, ranging from glomerular cysts to hydronephrosis and, rarely, multicystic dysplasia. Urinary proteomics uncovered a particular profile predictive of progressive decline in kidney function and fibrosis, and displayed common features with a recently reported urine proteome in an RCAD pediatric cohort. Altogether, our results show that reduced HNF1B levels lead to developmental disease phenotypes associated with the deregulation of a subset of HNF1B targets. They further suggest that this model represents a unique clinical/pathological viable model of the RCAD disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据